If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Gobbi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 44 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Leukemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1973 2019

A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia

Marcolin, R., Guolo, F., Minetto, P., Clavio, M., Manconi, L., Ballerini, F., Carli, A., Passannante, M., Colombo, N., Carminati, E., Pugliese, G., Tedone, E., Contini, P., Mangerini, R., Kunkl, A., Miglino, M., Cagnetta, A., Cea, M., Gobbi, M. & Lemoli, R. M., Nov 1 2019, In : Leukemia Research. 86, 106223.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Mutation
HLA-DR Antigens
Karyotype
Multivariate Analysis

Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas

Manconi, L., Coviello, E., Canale, F., Giannoni, L., Minetto, P., Guolo, F., Clavio, M., Marcolin, R., Cea, M., Cagnetta, A., Gobbi, M., Miglino, M., Ballerini, F. & Lemoli, R. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

oxaliplatin
Lymphoma, Large B-Cell, Diffuse
Cytarabine
Cell- and Tissue-Based Therapy
Dexamethasone
2 Citations (Scopus)

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation

Bernardi, S., Malagola, M., Zanaglio, C., Polverelli, N., Dereli Eke, E., D’Adda, M., Farina, M., Bucelli, C., Scaffidi, L., Toffoletti, E., Deambrogi, C., Stagno, F., Bergamaschi, M., Franceschini, L., Abruzzese, E., Divona, M. D., Gobbi, M., Di Raimondo, F., Gaidano, G., Tiribelli, M. & 4 others, Bonifacio, M., Cattaneo, C., Iurlo, A. & Russo, D., May 1 2019, In : Cancer Medicine. 8, 5, p. 2041-2055 15 p.

Research output: Contribution to journalArticle

Open Access
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Polymerase Chain Reaction
Protein-Tyrosine Kinases
Real-Time Polymerase Chain Reaction
Therapeutics

Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach

Guolo, F., Minetto, P., Clavio, M., Miglino, M., Colombo, N., Cagnetta, A., Cea, M., Marcolin, R., Todiere, A., Ballerini, F., Gobbi, M. & Lemoli, R. M., Sep 1 2019, In : British Journal of Haematology. 186, 6, p. e223-e225

Research output: Contribution to journalLetter

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia

Steurer, M., Montillo, M., Scarfò, L., Mauro, F. R., Andel, J., Wildner, S., Trentin, L., Janssens, A., Burgstaller, S., Frömming, A., Dümmler, T., Riecke, K., Baumann, M., Beyer, D., Vauléon, S., Ghia, P., Foà, R., Caligaris-Cappio, F. & Gobbi, M., Oct 1 2019, In : Haematologica. 104, 10, p. 2053-2060 8 p.

Research output: Contribution to journalArticle

Open Access
B-Cell Chronic Lymphocytic Leukemia
Oligoribonucleotides
Chemokine CXCL12
Patient Safety
Life Cycle Stages